dr. michaelis on unanswered questions in myelofibrosis treatment
Published 4 years ago • 79 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:59
dr. michaelis on fedratinib in myelofibrosis treatment
-
1:08
dr. mesa on unanswered questions regarding jak inhibitors in myelofibrosis
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
26:31
dr laura michaelis, md clinical trials 101
-
5:26
myelofibrosis explained: what you need to know
-
7:12
understanding drivers of progression in myelofibrosis
-
9:56
myelofibrosis: diagnosis and risk stratification
-
22:26
what's your approach? treating myelofibrosis
-
5:02
considering a myelofibrosis clinical trial? questions you should ask
-
0:49
dr. mims on the current challenges with myelofibrosis
-
5:58
mutations, diagnosis, and prognosis in myelofibrosis
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
1:47
dr. oh on the development of jak inhibitors in myelofibrosis
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
49:35
thursday webinars - primary myelofibrosis: diagnosis and treatment
-
5:11
optimal timing of jak inhibition in myelofibrosis
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
57:00
myelofibrosis: research to practice- are we making a difference?- dr. michael savona, 10/2/13
-
1:57
challenges in myelofibrosis management